Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
3
IMCC Quote, Financials, Valuation and Earnings
Last price:
$0.91
Seasonality move
:
2.19%
Day range:
$0.88 - $1.00
52-week range:
$0.88 - $7.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.09x
P/B ratio:
1.97x
Volume:
185.4K
Avg. volume:
71.6K
1-year change:
-56.36%
Market cap:
$5.6M
Revenue:
$39.4M
EPS (TTM):
-$0.79
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
$10.3M | -- | 31.7% | -- | -- |
|
IDTA
Identa Corp.
|
-- | -- | -- | -- | -- |
|
INMD
InMode Ltd.
|
$101.7M | $0.42 | 1.86% | 14.16% | $16.80 |
|
IRME
IR-Med, Inc.
|
-- | -- | -- | -- | -- |
|
PLUR
Pluri, Inc.
|
$638K | -$0.65 | 316.67% | -79.86% | $12.00 |
|
RAPH
Raphael Pharmaceutical, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
$0.95 | -- | $5.6M | -- | $0.00 | 0% | 0.09x |
|
IDTA
Identa Corp.
|
$0.30 | -- | $1.2M | 7.51x | $0.00 | 0% | 1.06x |
|
INMD
InMode Ltd.
|
$15.10 | $16.80 | $956.4M | 10.44x | $0.00 | 0% | 2.66x |
|
IRME
IR-Med, Inc.
|
$0.0010 | -- | $77.2K | -- | $0.00 | 0% | -- |
|
PLUR
Pluri, Inc.
|
$3.68 | $12.00 | $37M | -- | $0.00 | 0% | 22.48x |
|
RAPH
Raphael Pharmaceutical, Inc.
|
$1.40 | -- | $27.5M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
81.59% | 11.129 | 105.66% | 0.35x |
|
IDTA
Identa Corp.
|
43.33% | -0.998 | 89.15% | 2.59x |
|
INMD
InMode Ltd.
|
1.19% | 0.638 | 0.88% | 8.51x |
|
IRME
IR-Med, Inc.
|
-66.67% | 7.998 | 5.39% | 0.12x |
|
PLUR
Pluri, Inc.
|
172.93% | 0.066 | 98.32% | 0.40x |
|
RAPH
Raphael Pharmaceutical, Inc.
|
-3.35% | 3.461 | 0.52% | 0.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
$2M | -$3M | -25.37% | -135.96% | -29.98% | -$3M |
|
IDTA
Identa Corp.
|
$198.6K | $100.6K | -4.68% | -8.67% | 23.53% | $71K |
|
INMD
InMode Ltd.
|
$81.3M | $26M | 14.12% | 14.27% | 25.03% | $24.4M |
|
IRME
IR-Med, Inc.
|
-$4K | -$286K | -- | -- | -- | -$71K |
|
PLUR
Pluri, Inc.
|
-$43K | -$6.5M | -93.31% | -5662.45% | -3285.86% | -$5.7M |
|
RAPH
Raphael Pharmaceutical, Inc.
|
-- | -$251K | -- | -- | -- | -$17K |
IM Cannabis Corp. vs. Competitors
-
Which has Higher Returns IMCC or IDTA?
Identa Corp. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of 18.62%. IM Cannabis Corp.'s return on equity of -135.96% beat Identa Corp.'s return on equity of -8.67%.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M IDTAIdenta Corp.46.46% $0.02 $1.5M -
What do Analysts Say About IMCC or IDTA?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 530.87%. On the other hand Identa Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that IM Cannabis Corp. has higher upside potential than Identa Corp., analysts believe IM Cannabis Corp. is more attractive than Identa Corp..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 IDTAIdenta Corp.0 0 0 -
Is IMCC or IDTA More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison Identa Corp. has a beta of 0.551, suggesting its less volatile than the S&P 500 by 44.895%.
-
Which is a Better Dividend Stock IMCC or IDTA?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Identa Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. Identa Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or IDTA?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than Identa Corp. quarterly revenues of $427.5K. IM Cannabis Corp.'s net income of -$2.8M is lower than Identa Corp.'s net income of $79.6K. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while Identa Corp.'s PE ratio is 7.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.09x versus 1.06x for Identa Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.09x -- $10.1M -$2.8M IDTAIdenta Corp.1.06x 7.51x $427.5K $79.6K
-
Which has Higher Returns IMCC or INMD?
InMode Ltd. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of 26.02%. IM Cannabis Corp.'s return on equity of -135.96% beat InMode Ltd.'s return on equity of 14.27%.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M INMDInMode Ltd.78.28% $0.42 $691.4M -
What do Analysts Say About IMCC or INMD?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 530.87%. On the other hand InMode Ltd. has an analysts' consensus of $16.80 which suggests that it could grow by 11.3%. Given that IM Cannabis Corp. has higher upside potential than InMode Ltd., analysts believe IM Cannabis Corp. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 INMDInMode Ltd.0 6 0 -
Is IMCC or INMD More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison InMode Ltd. has a beta of 2.187, suggesting its more volatile than the S&P 500 by 118.719%.
-
Which is a Better Dividend Stock IMCC or INMD?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InMode Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. InMode Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or INMD?
IM Cannabis Corp. quarterly revenues are $10.1M, which are smaller than InMode Ltd. quarterly revenues of $103.9M. IM Cannabis Corp.'s net income of -$2.8M is lower than InMode Ltd.'s net income of $27M. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while InMode Ltd.'s PE ratio is 10.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.09x versus 2.66x for InMode Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.09x -- $10.1M -$2.8M INMDInMode Ltd.2.66x 10.44x $103.9M $27M
-
Which has Higher Returns IMCC or IRME?
IR-Med, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of --. IM Cannabis Corp.'s return on equity of -135.96% beat IR-Med, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M IRMEIR-Med, Inc.-- -$0.01 -$375K -
What do Analysts Say About IMCC or IRME?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 530.87%. On the other hand IR-Med, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that IM Cannabis Corp. has higher upside potential than IR-Med, Inc., analysts believe IM Cannabis Corp. is more attractive than IR-Med, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 IRMEIR-Med, Inc.0 0 0 -
Is IMCC or IRME More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison IR-Med, Inc. has a beta of 2.937, suggesting its more volatile than the S&P 500 by 193.663%.
-
Which is a Better Dividend Stock IMCC or IRME?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IR-Med, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. IR-Med, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or IRME?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than IR-Med, Inc. quarterly revenues of --. IM Cannabis Corp.'s net income of -$2.8M is lower than IR-Med, Inc.'s net income of -$701K. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while IR-Med, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.09x versus -- for IR-Med, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.09x -- $10.1M -$2.8M IRMEIR-Med, Inc.-- -- -- -$701K
-
Which has Higher Returns IMCC or PLUR?
Pluri, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of -3470.71%. IM Cannabis Corp.'s return on equity of -135.96% beat Pluri, Inc.'s return on equity of -5662.45%.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M PLURPluri, Inc.-21.72% -$0.71 $25.4M -
What do Analysts Say About IMCC or PLUR?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 530.87%. On the other hand Pluri, Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 226.09%. Given that IM Cannabis Corp. has higher upside potential than Pluri, Inc., analysts believe IM Cannabis Corp. is more attractive than Pluri, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 PLURPluri, Inc.1 0 0 -
Is IMCC or PLUR More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison Pluri, Inc. has a beta of 0.668, suggesting its less volatile than the S&P 500 by 33.181%.
-
Which is a Better Dividend Stock IMCC or PLUR?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pluri, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. Pluri, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or PLUR?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than Pluri, Inc. quarterly revenues of $198K. IM Cannabis Corp.'s net income of -$2.8M is higher than Pluri, Inc.'s net income of -$6.9M. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while Pluri, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.09x versus 22.48x for Pluri, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.09x -- $10.1M -$2.8M PLURPluri, Inc.22.48x -- $198K -$6.9M
-
Which has Higher Returns IMCC or RAPH?
Raphael Pharmaceutical, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of --. IM Cannabis Corp.'s return on equity of -135.96% beat Raphael Pharmaceutical, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M RAPHRaphael Pharmaceutical, Inc.-- -$0.01 -$1.2M -
What do Analysts Say About IMCC or RAPH?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 530.87%. On the other hand Raphael Pharmaceutical, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that IM Cannabis Corp. has higher upside potential than Raphael Pharmaceutical, Inc., analysts believe IM Cannabis Corp. is more attractive than Raphael Pharmaceutical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 RAPHRaphael Pharmaceutical, Inc.0 0 0 -
Is IMCC or RAPH More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison Raphael Pharmaceutical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IMCC or RAPH?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Raphael Pharmaceutical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. Raphael Pharmaceutical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or RAPH?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than Raphael Pharmaceutical, Inc. quarterly revenues of --. IM Cannabis Corp.'s net income of -$2.8M is lower than Raphael Pharmaceutical, Inc.'s net income of -$255K. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while Raphael Pharmaceutical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.09x versus -- for Raphael Pharmaceutical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.09x -- $10.1M -$2.8M RAPHRaphael Pharmaceutical, Inc.-- -- -- -$255K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
23
CAR alert for Feb 20
Avis Budget Group, Inc. [CAR] is down 21.87% over the past day.
Buy
75
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.
Sell
1
EPAM alert for Feb 20
EPAM Systems, Inc. [EPAM] is down 16.79% over the past day.
